Correlation Between Cadrenal Therapeutics, and Bellicum Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Cadrenal Therapeutics, and Bellicum Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cadrenal Therapeutics, and Bellicum Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cadrenal Therapeutics, Common and Bellicum Pharmaceuticals, you can compare the effects of market volatilities on Cadrenal Therapeutics, and Bellicum Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cadrenal Therapeutics, with a short position of Bellicum Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cadrenal Therapeutics, and Bellicum Pharmaceuticals.
Diversification Opportunities for Cadrenal Therapeutics, and Bellicum Pharmaceuticals
0.17 | Correlation Coefficient |
Average diversification
The 3 months correlation between Cadrenal and Bellicum is 0.17. Overlapping area represents the amount of risk that can be diversified away by holding Cadrenal Therapeutics, Common and Bellicum Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bellicum Pharmaceuticals and Cadrenal Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cadrenal Therapeutics, Common are associated (or correlated) with Bellicum Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bellicum Pharmaceuticals has no effect on the direction of Cadrenal Therapeutics, i.e., Cadrenal Therapeutics, and Bellicum Pharmaceuticals go up and down completely randomly.
Pair Corralation between Cadrenal Therapeutics, and Bellicum Pharmaceuticals
Given the investment horizon of 90 days Cadrenal Therapeutics, Common is expected to generate 2.37 times more return on investment than Bellicum Pharmaceuticals. However, Cadrenal Therapeutics, is 2.37 times more volatile than Bellicum Pharmaceuticals. It trades about 0.04 of its potential returns per unit of risk. Bellicum Pharmaceuticals is currently generating about 0.03 per unit of risk. If you would invest 0.15 in Cadrenal Therapeutics, Common on August 30, 2024 and sell it today you would earn a total of 1,415 from holding Cadrenal Therapeutics, Common or generate 943233.33% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 26.81% |
| Values | Daily Returns |
Cadrenal Therapeutics, Common vs. Bellicum Pharmaceuticals
Performance |
| Timeline |
| Cadrenal Therapeutics, |
| Bellicum Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Cadrenal Therapeutics, and Bellicum Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cadrenal Therapeutics, and Bellicum Pharmaceuticals
The main advantage of trading using opposite Cadrenal Therapeutics, and Bellicum Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cadrenal Therapeutics, position performs unexpectedly, Bellicum Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bellicum Pharmaceuticals will offset losses from the drop in Bellicum Pharmaceuticals' long position.The idea behind Cadrenal Therapeutics, Common and Bellicum Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| Bellicum Pharmaceuticals vs. Cellectis SA | Bellicum Pharmaceuticals vs. Adaptimmune Therapeutics Plc | Bellicum Pharmaceuticals vs. Atara Biotherapeutics | Bellicum Pharmaceuticals vs. Affimed NV |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Other Complementary Tools
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |